Cancer Cachexia-Pipeline Insights, 2014.

1
Cancer Cachexia-Pipeline Insights, 2014.
One-Stop Shop for Business Information
2
Summary
SUMMARY 'Cancer Cachexia-Pipeline Insights,
2014', report provides comprehensive insights
about pipeline drugs across this indication. A
key objective of the report is to establish the
understanding for all the pipeline drugs that
fall under Cancer Cachexia. This report provides
information on the therapeutic development based
on the Cancer Cachexia dealing with all the
pipeline drugs, comparative analysis at various
stages covering Filed, Phase III, Phase II, Phase
I, IND filed, Preclinical, Discovery and unknown
stages, therapeutics assessment by monotherapy
and combination products and molecule type drug
information. The report also covers the companies
information involved in the therapeutic
development of the products. It also has
highlighted the discontinued and dormant
products. Secondary sources information and
data has been collected from various printable
and non-printable sources like search engines,
News websites,
3
Government Websites, Trade Journals, White
papers, Magazines, Trade associations, Books,
Industry Portals, Industry Associations and
access to available databases. Scope The
report provides a snapshot of the global
therapeutic landscape of Cancer Cachexia.
The report provides pipeline products under drug
profile section which includes product
description, MOA, licensors collaborators,
development partner and chemical
information. Coverage of the Cancer Cachexia
pipeline on the basis of target, MOA, route
of administration, technology involved and
molecule type. The report reviews key players
involved in the therapeutics development for
Cancer Cachexia and also provide company
profiling
4

• The report also gives the information of
  dormant and discontinued pipeline
• projects
• Pipeline products coverage based on various
  stages of development
• ranging from preregistration till discovery
  and undisclosed stages
• Provides pipeline assessment by monotherapy and
  combination therapy
• products, stage of development and molecule
  type
• Reasons to buy
• Complete Pipeline intelligence and complete
  understanding over
• therapeutics development for Cancer Cachexia
• Identify the relationship between the drugs and
  use it for target finding,
• drug repurposing, and precision medicine.
• Devise corrective measures for pipeline
  projects by understanding Cancer
• Cachexia pipeline depth and focus of
  Indication therapeutics

5

• Developing strategic initiatives to support
  your drug development
• activities.
• Optimize your portfolio and keep you in touch
  with the rapidly changing
• pharmaceutical markets, and make the best
  decisions for your business.
• Develop and design in licensing and out
  licensing strategies by identifying
• prospective partners with the most attractive
  projects to enhance and
• expand business potential and scope
• Provides strategically significant competitor
  information, analysis, and
• insights to formulate effective RD
  development strategies
• Modify the therapeutic portfolio by identifying
  discontinued projects and
• understanding the factors that drove them from
  pipeline
• Gaining a Full Picture of the Competitive
  Landscape for Evidence based
• Decisions

6
Table Of Content

• Cancer Cachexia Overview
• Cancer Cachexia Pipeline Therapeutics
• Cancer Cachexia Therapeutics under Development
  by Companies
• Cancer Cachexia Late Stage Products (Filed and
  Phase III)
• Cancer Cachexia Mid Clinical Stage Products
  (Phase II)
• Cancer Cachexia Early Clinical Stage Products
  (Phase I and IND Filed)
• Cancer Cachexia Discovery and Pre-Clinical
  Stage Products
• Cancer Cachexia Therapeutics Assessment
• Assessment by Monotherapy Products
• Companies Involved in Therapeutics Development
  for Cancer Cachexia

7

• To know more
• Cancer Cachexia-Pipeline Insights, 2014.

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com